Literature DB >> 1567419

Chemical modification of L-asparaginase with a comb-shaped copolymer of polyethylene glycol derivative and maleic anhydride.

Y Kodera1, H Tanaka, A Matsushima, Y Inada.   

Abstract

L-Asparaginase from Escherichia coli, an anti-tumor enzyme, was chemically modified with two types of maleic anhydride copolymers with a comb-shaped form, the one composed of polyoxyethylene allyl methyl diether with the molecular weight of 13,000 (activated PM13) and the other of polyoxyethylene 2-methyl-2-propenyl methyl diether with 100,000 (activated PM100). The modified asparaginases (PM13- and PM100-asparaginases) exhibited the complete loss of immunoreactivity towards anti-asparaginase serum. The enzymic activity of PM100-asparaginase without immunoreactivity was well retained by 85% of non-modified one, while that of PM13-asparaginase was retained 46%. These results were discussed in relation to the chemical structure of modifying reagents including chain shaped-polyethylene glycol derivatives.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567419     DOI: 10.1016/0006-291x(92)91170-u

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.

Authors:  H O Ito; T So; M Hirata; T Koga; T Ueda; T Imoto
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  A multiple-dose pharmacokinetics of polyethylene glycol recombinant human interleukin-6 (PEG-rhIL-6) in rats.

Authors:  Xue-ling He; Hai-lin Yin; Jiang Wu; Ke Zhang; Yan Liu; Tao Yuan; Hai-lin Rao; Liang Li; Guang Yang; Xue-mei Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2011-01       Impact factor: 3.066

3.  Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.

Authors:  Z B Moola; M D Scawen; T Atkinson; D J Nicholls
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.